---
$id: https://graph.org.ai/products/commodity/51151665
$type: Product
source: UNSPSC
code: "51151665"
title: "Zamifenacin"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zamifenacin

**UNSPSC Code**: 51151665
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C27H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y88Q418Y7M, chemically known as piperidine, 1-(2-(1,3-benzodioxol-5-yl)ethyl)-3-(diphenylmethoxy)-, (+-)- but generally known as zamifenacin, which bears US NIH Compound Identifier 124431. European Medicines Agency schedules Zamifenacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00136MIG. The term ZAMIFENACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ZAMIFENACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zamifenacin under HS 29349990 and SITC 51579. As of Q4 2014, ZAMIFENACIN remains the US FDA Preferred Term for this commodity. Zamifenacin bears US NLM identifiers UMLS ID C0386392 and NCI Concept Code C66682. SMILES: O(C1CN(CCC1)CCC1CC2OCOC2CC1)C(C1CCCCC1)C1CCCCC1.

